← Scroll for more →
Amphastar Pharmaceuticals, Inc. (AMPH)
Pharmaceutical Preparations
Latest Price
$25.81
TTM P/E
15.27
Normalized P/E
11.52
Div Yield
--
Book Value
17.42
P/B Ratio
1.48
Valuation metrics
adjust assumptions →EPS: $2.03
Book value / share: $17.28
Formula: √(22.5 × EPS × BVPS)
Graham Number
$28.09
+9% upside
Norm. op. income: $107M (median of 7yr)
Tax rate: 21%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$11.55
55% downside
Base FCF: $121M (median of recent 5yr)
Growth: 22%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$149.57
+479% upside
EPS: $2.03
Target P/E: 12×
Formula: EPS × P/E
P/E Fair Value
$24.36
6% downside
Institutional Ownership
66.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.22M | $105.0M | 12.28% | -196.4K | 2026-06-30 |
| Dimensional Fund Advisors LP | 2.31M | $46.0M | 5.42% | +277.2K | 2026-06-30 |
| State Street Corp | 1.64M | $33.0M | 3.86% | +34.6K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.48M | $29.0M | 3.48% | -61.7K | 2026-06-30 |
| American Century Companies Inc | 1.18M | $23.0M | 2.77% | +159.1K | 2026-06-30 |
| Marshall Wace, LLP | 1.07M | $21.0M | 2.51% | +40.7K | 2026-06-30 |
| Geode Capital Management, LLC | 969.8K | $19.0M | 2.28% | -6.8K | 2026-06-30 |
| Fuller & Thaler Asset Management, Inc. | 949.2K | $19.0M | 2.23% | -445.9K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 887.0K | $17.0M | 2.09% | +221.5K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 809.6K | $16.0M | 1.90% | +21.8K | 2026-06-30 |